Heritage Wealth Management (Arizona)’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$776 Buy
200
+100
+100% +$308 ﹤0.01% 1037
2022
Q3
$0 Hold
100
– – ﹤0.01% 1004
2022
Q2
$198 Hold
100
– – ﹤0.01% 969
2022
Q1
$0 Buy
+100
New +$156 ﹤0.01% 972
2021
Q3
$0 Hold
100
– – ﹤0.01% 884
2021
Q2
$1K Buy
+100
New +$176 ﹤0.01% 849

Other funds holding ADMA

Heritage Wealth Management (Arizona)'s ADMA Position: Q4 2022 in Review

Heritage Wealth Management (Arizona) increased its ADMA Biologics (ADMA) stake by 100% in Q4 2022, buying an estimated $308 and bringing the position to 200 shares worth $776. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Heritage Wealth Management (Arizona) first reported a position in ADMA in Q2 2021 and has held it in 6 quarters since. The position peaked at $1K in Q2 2021. 159 funds tracked by Wall St. Rank hold ADMA as of Q4 2022.

  • Heritage Wealth Management (Arizona) held 200 shares of ADMA Biologics worth $776 as of Q4 2022.
  • Heritage Wealth Management (Arizona) bought 100 ADMA Biologics shares in Q4 2022, an estimated $308.
  • ADMA Biologics made up ﹤0.01% of Heritage Wealth Management (Arizona)'s portfolio in Q4 2022, its #1037 holding.
  • Heritage Wealth Management (Arizona) first reported a position in ADMA Biologics in Q2 2021 and has held it in 6 quarters since.
  • Heritage Wealth Management (Arizona)'s ADMA Biologics position peaked at $1K in Q2 2021.
  • 159 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2022.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q4 2022, filed 13 Feb 2023.